Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
01/1997
01/09/1997WO1997000941A2 Novel system for multilayer growth of anchorage-dependent cells
01/09/1997WO1997000888A1 Methods for reducing background binding in antibody preparations
01/09/1997WO1997000698A1 Inhibition of hepatitis b replication
01/09/1997WO1997000695A1 Haemopoietic growth factor antagonists and uses therefor
01/09/1997WO1996038560A3 Genetic control of flowering
01/09/1997WO1996030540A3 Substrates for beta-lactamase and uses thereof
01/09/1997CA2225600A1 Gibberellin-regulated myb polypepetides
01/09/1997CA2225517A1 Haemopoietic growth factor antagonists and uses therefor
01/09/1997CA2225460A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors
01/09/1997CA2224995A1 Antigen non-specific glycosylation inhibiting factor derivatives
01/09/1997CA2224799A1 A human edg-2 receptor homolog
01/09/1997CA2224797A1 Immortalized epithelial tumor cell
01/09/1997CA2224687A1 Methods for reducing background binding in antibody preparations
01/09/1997CA2224477A1 Inhibition of hepatitis b replication
01/09/1997CA2224247A1 Human homolog of the mouse rab18 gene
01/09/1997CA2222270A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses
01/08/1997EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
01/08/1997EP0752104A1 Differential expansion of fetal stem cells in the maternal circulation for use in prenatal genetic analysis
01/08/1997EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf)
01/08/1997EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
01/08/1997EP0751996A1 Luciferases
01/08/1997EP0751995A1 Riboflavin synthesis in fungi
01/08/1997EP0751992A1 Vascular endothelial growth factor 2
01/08/1997EP0751988A1 Highly efficient production and isolation of viral particles
01/08/1997EP0751962A1 Methods and compositions for inhibiting cd14 mediated cell activation
01/08/1997EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases
01/08/1997EP0751955A1 Super proteins including interferons and interleukins
01/08/1997EP0751951A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
01/08/1997EP0751784A1 Thyroxin-binding proteins
01/08/1997EP0751780A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods
01/08/1997EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
01/08/1997EP0706320B1 Method of controlling insects
01/08/1997EP0497828B1 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
01/08/1997EP0473724B1 A human cytokine, interleukin-9
01/08/1997EP0386166B1 PROTAMINE-REACTIVE IgM ANTIBODIES
01/08/1997CN1139955A Human kunitz-type protease inhibitors
01/08/1997CN1139871A Novel apopotsis-modulating proteins, DNA encoding the proteins and methods of use thereof
01/08/1997CN1139703A Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell
01/08/1997CN1033760C Protein with 8th activity factor, process for its preparation using genetic engineering cell and pharmaceutical composition containing it
01/07/1997US5591828 Genetic engineering
01/07/1997US5591822 Hydrophobic attachment site for adhesion peptides
01/07/1997US5591639 Plasmids and gene expression for dna sequences
01/07/1997US5591629 Monoclonal antibodies which promote central nervous system remyelination
01/07/1997US5591627 Circulation of cell medium over substrate with patterns of adhesive such as collagen
01/07/1997US5591624 Retroviral packaging cell lines
01/07/1997US5591623 Oligonucleotide modulation of cell adhesion
01/07/1997US5591620 Methods of detecting and isolating a ripening form of a polypeptide having rhamnogalacturonase activity
01/07/1997US5591616 Method for transforming monocotyledons
01/07/1997US5591602 Nucleic acid encoding opioid receptor
01/07/1997US5591598 Method for quantitating hydrazide groups
01/07/1997US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor
01/07/1997US5591579 Indicator cell line for detecting RNA viruses and method therefor
01/07/1997US5591444 Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
01/07/1997US5591440 Hepatitis B Virus mutants, reagents and methods for detection
01/07/1997CA1338829C Superior mammalian expression system
01/07/1997CA1338827C Fruit-specific transcriptional factors
01/03/1997WO1997000326A1 Packaging systems for human recombinant adenovirus to be used in gene therapy
01/03/1997WO1997000319A2 Chimeric leptin fused to immunoglobulin domain and use
01/03/1997WO1997000316A1 A process for producing trypsin (trypsinogen)
01/03/1997WO1996037621A3 Multimeric proteins
01/03/1997CA2224646A1 Chimeric leptin fused to immunoglobulin domain and use
01/02/1997EP0751217A2 Enhancing keratinocyte migration with clostridiopeptidase-A-collagenase
01/02/1997EP0751147A1 Toxoplasma gondii antigen, its production and use
01/02/1997EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof
01/02/1997EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)
01/02/1997EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b))
01/02/1997EP0750673A1 Transgenic production of oligosaccharides and glycoconjugates
01/02/1997EP0750672A1 Dna sequences for matrix metalloproteases, their production and use
01/02/1997EP0750671A1 Transgenic animals producing oligosaccharides and glycoconjugates
01/02/1997EP0750664A1 Reproduction and utilization of functional human tissue
01/02/1997EP0750626A1 Corpuscles of stannius protein, stanniocalcin
01/02/1997EP0750516A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides
01/02/1997EP0750505A1 Immunotherapy of cancer with allogeneic lymphocytes
01/02/1997EP0750503A1 Ribozyme therapy for restenosis
01/02/1997EP0750458A1 Terminal complement inhibitor fusion genes and proteins
01/02/1997EP0750457A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
01/02/1997EP0691806A4 Method of causing somatic hybridization between two species of algae
01/02/1997EP0556345B1 Retroviral vectors useful for gene therapy
01/02/1997DE19526386C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
01/01/1997CN1139455A Thrombin mutants
01/01/1997CN1139115A Anti-aV-integrin monoclonal antibody
12/1996
12/31/1996US5589624 Antifungal polypeptide and process for its production
12/31/1996US5589621 Transformed plant cell
12/31/1996US5589620 Isolated from plants; useful in transforming vectors, host organisms and plants; produce plants which exhibit an increased resistance towards pests
12/31/1996US5589619 Increasing the amount of a gene encoding a polypeptide having hmg-coa reductase activity
12/31/1996US5589614 Plant-derived glutathione-S-transferase isoform II promoter
12/31/1996US5589610 Stamen-specific promoters from corn
12/31/1996US5589582 Polynucleotides en coding porcine cytokines
12/31/1996US5589573 Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and DNA base sequences encoding those sequences
12/31/1996US5589384 Formation of pentamer complex and binding to gangliosides and hinges of glycineproline and antigens or epitopes
12/31/1996US5589379 Geminivirus-based gene expression system
12/31/1996US5589377 Cells and genetic engineering
12/31/1996US5589376 Cloning, transplanting
12/31/1996US5589374 Diabetogene rad: a type II diabetes specific gene
12/31/1996US5589369 Cells homozygous for disrupted target loci
12/31/1996US5589345 Leukemia cells
12/31/1996US5589338 Nucleic acids encoding a mutant form of human serum albumin involved in familial dysalbuminemic hyperthyroxinemia
12/31/1996US5589334 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor which is processed to an antigen presented by HLA-B44, and uses thereof
12/31/1996US5589112 Constructing a high density cell culture system
12/31/1996US5589047 Using dielectrophoresis for genetic engineering